NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE76087 Query DataSets for GSE76087
Status Public on Jun 06, 2017
Title Modulating the gut microbiota by dietary guar gum protects against diet-induced obesity but promotes non-alcoholic steatohepatitis in mice
Organism Mus musculus
Experiment type Expression profiling by array
Summary Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide, yet the pathogenesis of NAFLD is only partially understood. Here, we investigated the role of the gut bacteria in NAFLD by stimulating the gut bacteria via feeding mice the fermentable dietary fiber guar gum and suppressing the gut bacteria via chronic oral administration of antibiotics. Guar gum feeding profoundly altered the gut microbiota composition, in parallel with reduced diet-induced obesity and improved glucose tolerance. Strikingly, despite reducing adipose tissue mass and inflammation, guar gum enhanced hepatic inflammation and fibrosis, concurrent with markedly elevated plasma and hepatic bile acid levels. Consistent with a role of elevated bile acids in the liver phenotype, treatment of mice with taurocholic acid stimulated hepatic inflammation and fibrosis. In contrast to guar gum, chronic oral administration of antibiotics effectively suppressed the gut bacteria, decreased portal secondary bile acid levels, and attenuated hepatic inflammation and fibrosis. Neither guar gum or antibiotics influenced plasma lipopolysaccharide levels. In conclusion, our data indicate a causal link between changes in gut microbiota and hepatic inflammation and fibrosis in a mouse model of NAFLD, possibly via alterations in bile acids.
 
Overall design Mice were fed a high-fat, high-cholesterol diet, together with a 20% fructose solution as drinking water, or the same diet in which 10% corn starch (w/w) was replaced by the dietary fiber guar gum. After 18 wks of intervention, livers were removed and used for gene expression profiling.
 
Contributor(s) Janssen AW, Houben T, Katiraei S, Boutens L, van der Bolt N, Wang Z, Brown JM, Hazen SL, Shiri-Sverdlov R, Willems van Dijk K, Vervoort J, Stienstra R, Hooiveld GJ, Kersten S
Citation(s) 28533304
Submission date Dec 16, 2015
Last update date Jun 08, 2017
Contact name Guido Hooiveld
E-mail(s) guido.hooiveld@wur.nl
Organization name Wageningen University
Department Div. Human Nutrition & Health
Lab Nutrition, Metabolism & Genomics Group
Street address HELIX, Stippeneng 4
City Wageningen
ZIP/Postal code NL-6708WE
Country Netherlands
 
Platforms (1)
GPL11533 [MoGene-1_1-st] Affymetrix Mouse Gene 1.1 ST Array [transcript (gene) version]
Samples (16)
GSM1973991 Liver_Mouse_HFCFD_rep1
GSM1973992 Liver_Mouse_HFCFD_GuarGum_rep1
GSM1973993 Liver_Mouse_HFCFD_rep2
Relations
BioProject PRJNA306172

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE76087_RAW.tar 71.4 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap